查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722826

2025 年至 2033 年藥物傳遞市場規模、佔有率、趨勢及預測（按給藥途徑、應用、最終用戶和地區）

Pharmaceutical Drug Delivery Market Size, Share, Trends, and Forecast by Route of Administration, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球藥物輸送市場規模價值為 14,652 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 22,055 億美元，2025-2033 年期間的複合年成長率為 4.6%。北美目前佔據市場主導地位，到 2024 年將佔據 42.6% 的顯著市場。對有針對性和高效藥物輸送系統的需求不斷成長、對促進藥物輸送創新的個人化醫療的日益關注以及奈米技術的眾多進步是推動市場佔有率成長的一些主要因素。

藥物輸送市場分析：

主要市場促進因素：慢性病盛行率的不斷上升增加了對標靶治療的需求，進而催化了市場的成長。此外，由於患者獨特的基因特徵需要客製化的藥物管理方法，對個人化藥物的需求不斷成長也促進了市場的成長。

主要市場趨勢：奈米技術和生物材料的許多進步促進了精確的藥物傳遞機制，實現了控制釋放和更好的生物利用度，對市場成長產生了積極影響。此外，擴大採用使用者友善的藥物輸送系統來滿足老年患者的特定需求也是推動市場成長的另一個重要趨勢。

地理格局：根據報告，北美在全球市場中佔據最大的市場佔有率，因為該地區擁有強大的醫療保健基礎設施、強大的研發能力以及較高的慢性病盛行率。

競爭格局：一些領先的藥物輸送市場公司包括 AbbVie Inc.、Amgen Inc.、AstraZeneca plc、Becton Dickinson and Company、Eli Lilly and Company、GSK plc、Johnson & Johnson、Merck KGaA、Novartis AG、Pfizer Inc. 和 Sanofi SA 等。

挑戰與機會：全球藥物輸送市場的挑戰包括監管障礙、複雜的製造流程以及持續創新的需要。藥物傳輸市場近期的機會包括慢性病盛行率的上升、對標靶和控制藥物傳輸系統的需求不斷成長，以及奈米技術和生物製劑的進步。

藥物輸送市場趨勢：

標靶治療需求不斷成長

針對性治療需求的不斷成長是藥物傳輸市場的重要動力。傳統的全身給藥常常導致脫靶效應和不良反應，這增加了對標靶治療和藥物傳遞的需求。此外，COVID-19 等各種危及生命的感染日益流行，也促使製造商推出有效的藥物輸送設備和技術。預計這將在未來幾年對藥物輸送市場的成長做出重大貢獻。例如，2022 年 2 月，Glenmark Pharmaceuticals Limited 在印度推出了一種名為 FabiSpray 的一氧化氮鼻噴劑，用於治療病情進展風險較高的 COVID-19 成年患者。此外，2020年7月Frontiers發表的文章提到，治療糖尿病需要根據藥物的性質，制定適當的給藥系統和完整的治療策略。消息人士透露，藥物輸送裝置在糖尿病治療的各個方面都顯示出巨大的潛力。它們增強了藥物的穩定性，克服了生物屏障，提高了生物利用度，並充當了模擬自然胰島素輸送的智慧自動化系統，降低了低血糖的風險。

科技快速進步

藥物輸送設備和技術的不斷進步使其更加患者友好、易於使用和準確，進一步促進了全球藥物傳輸市場的成長。除此之外，各主要市場參與者正大力投資先進藥物輸送裝置的開發與創新。例如，2021 年 5 月，Phillips-Medisize 推出了其 Aria Smart Autoinjector 平台，該平台開啟了製藥業的創新、差異化和永續性。該設備採用先進的技術，例如模組化藥物傳輸平台，支援多種藥物配方和黏度，並具有內建藍牙，可連接智慧型手機、平板電腦和行動應用程式。同樣，2021 年 6 月，羅氏開發了一種帶有雷珠單抗 (PDS)（一種藥物輸送植入物）的港口輸送系統，使患有濕性老年黃斑部病變的患者無需頻繁進行眼部注射。預計此類創新和技術進步將在未來幾年推動藥物輸送市場收入的成長。

慢性病盛行率不斷上升

世界各地各種慢性病病例的增加增加了對藥品的需求。根據世界衛生組織（WHO）的數據，慢性病是全球最大的死亡原因。光是缺血性心臟病一項，在2019年就造成了約889萬人死亡。此外，全球癌症、呼吸系統疾病和糖尿病患者的發生率不斷上升，進一步推動了藥物輸送裝置的普及。根據國際癌症研究機構2020年發布的資料，全球每5人中就有1人在其一生中患有癌症，每8名男性中就有1人、每11名女性中就有1人死於癌症。乳癌、大腸癌、肺癌、子宮頸癌和甲狀腺癌在女性中很常見。而肺癌和攝護腺癌在男性中最為常見，佔所有男性癌症的近三分之一。此外，根據印度國立衛生研究院發布的《2022年慢性病盛行率和潛在決定因素》報告，印度約有21%的老年人口患有至少一種慢性病。預計慢性病病例的增加將增加藥品輸送市場的需求。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球藥物輸送市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依行政途徑

  • 口服給藥
  • 注射藥物輸送
  • 局部給藥
  • 眼部藥物輸送
  • 肺部藥物輸送
  • 植入式藥物輸送
  • 經由黏膜給藥
  • 鼻腔給藥

第7章：市場區隔：依應用

  • 傳染病
  • 癌症
  • 心血管疾病
  • 糖尿病
  • 呼吸系統疾病
  • 中樞神經系統疾病
  • 自體免疫疾病
  • 其他

第8章：市場區隔：按最終用戶

  • 醫院
  • 門診手術中心
  • 居家照護環境
  • 診斷中心
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca plc
    • Becton Dickinson and Company
    • Eli Lilly and Company
    • GSK plc
    • Johnson & Johnson
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
Product Code: SR112025A5796

The global pharmaceutical drug delivery market size was valued at USD 1,465.2 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,205.5 Billion by 2033, exhibiting a CAGR of 4.6% during 2025-2033. North America currently dominates the market, holding a significant market share of 42.6% in 2024. The rising demand for targeted and efficient drug delivery systems, increasing focus on personalized medicine fostering drug delivery innovations, and numerous advancements in nanotechnology are some of the major factors propelling the market share.

Pharmaceutical Drug Delivery Market Analysis:

Major Market Drivers: The increasing prevalence of chronic diseases is augmenting the demand for targeted therapies, which in turn is catalyzing the market growth. Furthermore, the rising need for personalized medication as unique genetic profiles of patients require tailored drug administration methods is also contributing to the market growth.

Key Market Trends: Numerous advancements in nanotechnology and biomaterials that facilitate precise drug delivery mechanisms, allowing for controlled release and better bioavailability, are positively influencing market growth. Moreover, the rising adoption of user-friendly drug delivery systems that can cater to the specific needs of elderly patients is also acting as another significant trend, driving the market growth.

Geographical Landscape: According to the report, North America accounted for the largest market share in the global market since the region has a robust healthcare infrastructure, strong research and development (R&D) capabilities, and a high prevalence of chronic diseases.

Competitive Landscape: Some of the leading pharmaceutical drug delivery market companies are AbbVie Inc., Amgen Inc., AstraZeneca plc, Becton Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi S.A., among many others.

Challenges and Opportunities: Challenges in the global pharmaceutical drug delivery market include regulatory hurdles, complex manufacturing processes, and the need for continuous innovation. Pharmaceutical drug delivery market recent opportunities include increasing prevalence of chronic diseases, growing demand for targeted and controlled drug delivery systems, and advancements in nanotechnology and biologics.

Pharmaceutical Drug Delivery Market Trends:

Rising Demand for Targeted Therapies

The escalating demand for targeted therapies is a significant driver in the pharmaceutical drug delivery market. Traditional systemic drug administration often results in off-target effects and adverse reactions, which augment the need for targeted therapies and drug deliveries. Moreover, the growing prevalence of various life-threatening infections, such as COVID-19, is also prompting manufacturers to introduce effective drug-delivery devices and techniques. This is anticipated to significantly contribute to the pharmaceutical drug delivery market growth in the coming years. For instance, in February 2022, Glenmark Pharmaceuticals Limited launched a nitric oxide nasal spray called FabiSpray in India for the treatment of adult patients with COVID-19 who had a high risk of progression of the disease. Besides this, the article published by Frontiers in July 2020 mentioned that it is necessary to develop appropriate delivery systems and complete therapy strategies according to the nature of drugs in treating diabetes mellitus. As per the source, drug-delivery devices have shown significant potential in various aspects of diabetes treatment. They enhance the stability of drugs, overcome biological barriers to increase bioavailability, and act as a smart, automated system to mimic natural insulin delivery, reducing the risk of hypoglycemia.

Rapid Technological Advancements

Ongoing technological advancements in drug delivery devices and techniques to make them more patient-friendly, accessible, and accurate are further catalyzing the growth of the global pharmaceutical drug delivery market. In addition to this, various key market players are extensively investing in the development and innovation of advanced drug-delivery devices. For instance, in May 2021, Phillips-Medisize launched its Aria Smart Autoinjector platform, which unlocked innovation, differentiation, and sustainability in the pharmaceutical industry. This device features advanced technologies such as a modular drug delivery platform that supports a variety of drug formulations and viscosities and has built-in Bluetooth, which enables connectivity to smartphones, tablets, and mobile apps. Similarly, in June 2021, Roche developed a Port Delivery System with ranibizumab (PDS), a drug delivery implant, to free patients with wet age-related macular degeneration from the need to undergo frequent eye injections. Such innovations and technological advancements are anticipated to propel the pharmaceutical drug delivery market revenue in the coming years.

Increasing Prevalence of Chronic Diseases

The rising cases of various chronic ailments across the world are augmenting the demand for medicines and drugs. According to the World Health Organization (WHO), chronic diseases are the leading cause of death worldwide. Ischemic heart disease alone was responsible for about 8.89 million deaths in 2019. Moreover, the increasing prevalence of cancer, respiratory disease, and diabetic patients across the world is further promoting the adoption of drug delivery devices. According to the data published by the International Agency for Research on Cancer 2020, globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die. Breast, colorectal, lung, cervical, and thyroid cancers are common among women. Whereas lung and prostate cancer are the most common among men, accounting for nearly one-third of all male cancers. Furthermore, according to a report published by the National Institute of Health, India, on Prevalence and Potential Determinants of Chronic Diseases, 2022, about 21% of the elderly population in India reportedly have at least one chronic disease. The escalating cases of chronic ailments are projected to bolster the pharmaceutical drug delivery market demand.

Global Pharmaceutical Drug Delivery Industry Segmentation:

Breakup by Route of Administration:

  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Implantable Drug Delivery
  • Transmucosal Drug Delivery
  • Nasal Drug Delivery

Oral drug delivery represents the most popular route of administration

Pharmaceutical drug delivery market forecast indicates that oral drug delivery is a prominent route of administration where pharmaceutical compounds are ingested through the mouth and absorbed in the gastrointestinal tract. Oral medications are convenient to administer, making it a preferred choice for various medications. Moreover, the rise in R&D activities and product launches are likely to positively impact the pharmaceutical drug delivery market outlook. For instance, in June 2021, Shilpa Medicare Ltd. launched Molshil, a pediatric dose of paracetamol oral thin film, in India. Furthermore, according to the WHO, in 2021, approximately 275 million people used medications (drugs) at least once. Among them, approximately 62 million people used opioids.

Breakup by Application:

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Others

Infectious diseases account for the majority of the market share

Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, and parasites, which can spread from person to person or through contaminated objects. As per the pharmaceutical drug delivery market report by IMARC, the rising prevalence of infectious diseases poses significant global health challenges, necessitating effective treatment strategies. For instance, according to an article by Frontiers in February 2022, non-typhoidal Salmonella, a common cause of bacterial enteritis in humans, causes almost 93.8 million cases of gastroenteritis globally each year.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Home Care Settings
  • Diagnostic Centers
  • Others

As per the pharmaceutical drug delivery market overview by IMARC, hospitals hold a significant share in the global market. Hospitals as primary care providers utilize a variety of drug delivery methods to ensure effective treatment for diverse patient needs. Ambulatory Surgery Centers demand specialized drug delivery techniques for perioperative care and pain management. Home Care Settings require user-friendly delivery systems for patient self-administration, promoting adherence and comfort. Diagnostic Centers rely on targeted drug delivery to enhance imaging and therapeutic interventions.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

As per the pharmaceutical drug delivery market statistics by IMARC, North America held the biggest share in the market since the region has a robust healthcare infrastructure, strong research and development (R&D) capabilities, and a high prevalence of chronic diseases. For instance, according to the American Cancer Society's 2022 report, approximately 1.9 million new cancer cases were diagnosed in 2022 in the United States. Besides this, the presence of leading manufacturers in the region, along with the introduction of new products, is also bolstering the growth of the market in North America. For instance, in February 2022, the United States FDA approved the generic Apokyn (apomorphine hydrochloride injection) drug cartridges to treat hypomobility and other episodes associated with advanced Parkinson's disease.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • Becton Dickinson and Company
  • Eli Lilly and Company
  • GSK plc
  • Johnson & Johnson
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Pharmaceutical Drug Delivery Market Recent Developments

January 2024: Berry Global Healthcare, a patient-centered package design company, showcased its latest range of standard and bespoke pharmaceutical packaging solutions at Pharmapack 2024. The exhibition witnessed the launch of the BerryHaler, an all-plastic, dual chamber, dry powder inhaler (DPI) designed to deliver combination drugs and separately store two medications for subsequent simultaneous inhalation.

October 2023: Victrex plc, a pioneer in the development of PEEK biomaterial solutions launched a new product grade developed exclusively for Drug Delivery and Pharmaceutical Contact applications. VICTREX PC101 meets the highest levels of Industry biocompatibility certification for USP Class VI and also meets industry standards such as USP 661 for use in non-implantable pharmaceutical contact applications.

July 2023: Viatris Inc., a global healthcare company, and Kindeva Drug Delivery L.P. announced the launch of Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort. It comes with an Abbreviated New Drug Application (ANDA) and is approved by the U.S. Food and Drug Administration (FDA).

Key Questions Answered in This Report

  • 1.What is pharmaceutical drug delivery?
  • 2.How big is the pharmaceutical drug delivery market?
  • 3.What is the expected growth rate of the global pharmaceutical drug delivery market during 2025-2033?
  • 4.What are the key factors driving the global pharmaceutical drug delivery market?
  • 5.What is the leading segment of the global pharmaceutical drug delivery market based on the route of administration?
  • 6.What is the leading segment of the global pharmaceutical drug delivery market based on application?
  • 7.What is the leading segment of the global pharmaceutical drug delivery market based on end user?
  • 8.What are the key regions in the global pharmaceutical drug delivery market?
  • 9.Who are the key players/companies in the global pharmaceutical drug delivery market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Drug Delivery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Route of Administration

  • 6.1 Oral Drug Delivery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Injectable Drug Delivery
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Topical Drug Delivery
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Ocular Drug Delivery
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Pulmonary Drug Delivery
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Implantable Drug Delivery
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Transmucosal Drug Delivery
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Nasal Drug Delivery
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Infectious Diseases
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cancer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Diabetes
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Respiratory Diseases
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Central Nervous System Disorders
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Autoimmune Diseases
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Home Care Settings
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Diagnostic Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 AstraZeneca plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GSK plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Novartis AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Pfizer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: Pharmaceutical Drug Delivery Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Drug Delivery Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Pharmaceutical Drug Delivery Market: Breakup by Route of Administration (in %), 2024
  • Figure 5: Global: Pharmaceutical Drug Delivery Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Pharmaceutical Drug Delivery Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Pharmaceutical Drug Delivery Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Pharmaceutical Drug Delivery (Oral Drug Delivery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Pharmaceutical Drug Delivery (Oral Drug Delivery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Pharmaceutical Drug Delivery (Injectable Drug Delivery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Pharmaceutical Drug Delivery (Injectable Drug Delivery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Pharmaceutical Drug Delivery (Topical Drug Delivery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Pharmaceutical Drug Delivery (Topical Drug Delivery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Pharmaceutical Drug Delivery (Ocular Drug Delivery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Pharmaceutical Drug Delivery (Ocular Drug Delivery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Pharmaceutical Drug Delivery (Pulmonary Drug Delivery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Pharmaceutical Drug Delivery (Pulmonary Drug Delivery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Pharmaceutical Drug Delivery (Implantable Drug Delivery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Pharmaceutical Drug Delivery (Implantable Drug Delivery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Pharmaceutical Drug Delivery (Transmucosal Drug Delivery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Pharmaceutical Drug Delivery (Transmucosal Drug Delivery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Pharmaceutical Drug Delivery (Nasal Drug Delivery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Pharmaceutical Drug Delivery (Nasal Drug Delivery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Pharmaceutical Drug Delivery (Infectious Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Pharmaceutical Drug Delivery (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Pharmaceutical Drug Delivery (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Pharmaceutical Drug Delivery (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Pharmaceutical Drug Delivery (Cardiovascular Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Pharmaceutical Drug Delivery (Cardiovascular Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Pharmaceutical Drug Delivery (Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Pharmaceutical Drug Delivery (Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Pharmaceutical Drug Delivery (Respiratory Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Pharmaceutical Drug Delivery (Respiratory Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Pharmaceutical Drug Delivery (Central Nervous System Disorders) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Pharmaceutical Drug Delivery (Central Nervous System Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Pharmaceutical Drug Delivery (Autoimmune Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Pharmaceutical Drug Delivery (Autoimmune Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Pharmaceutical Drug Delivery (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Pharmaceutical Drug Delivery (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Pharmaceutical Drug Delivery (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Pharmaceutical Drug Delivery (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Global: Pharmaceutical Drug Delivery (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Global: Pharmaceutical Drug Delivery (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Global: Pharmaceutical Drug Delivery (Home Care Settings) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Global: Pharmaceutical Drug Delivery (Home Care Settings) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Global: Pharmaceutical Drug Delivery (Diagnostic Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Global: Pharmaceutical Drug Delivery (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Global: Pharmaceutical Drug Delivery (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Global: Pharmaceutical Drug Delivery (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: North America: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: North America: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: United States: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: United States: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Canada: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Canada: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Asia-Pacific: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Asia-Pacific: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: China: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: China: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Japan: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Japan: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: India: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: India: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: South Korea: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: South Korea: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Australia: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Australia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Indonesia: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Indonesia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Europe: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Europe: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Germany: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Germany: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: France: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: France: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: United Kingdom: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: United Kingdom: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Italy: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Italy: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Spain: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Spain: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Russia: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Russia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Latin America: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Latin America: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Brazil: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 91: Brazil: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Mexico: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 93: Mexico: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 94: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 95: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 96: Middle East and Africa: Pharmaceutical Drug Delivery Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 97: Middle East and Africa: Pharmaceutical Drug Delivery Market: Breakup by Country (in %), 2024
  • Figure 98: Middle East and Africa: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 99: Global: Pharmaceutical Drug Delivery Industry: SWOT Analysis
  • Figure 100: Global: Pharmaceutical Drug Delivery Industry: Value Chain Analysis
  • Figure 101: Global: Pharmaceutical Drug Delivery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Drug Delivery Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 3: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Pharmaceutical Drug Delivery Market: Competitive Structure
  • Table 7: Global: Pharmaceutical Drug Delivery Market: Key Players